Cargando…
Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS‐ICOSL interaction
Group 2 innate lymphoid cells (ILC2s) are recognized as key controllers and effectors of type 2 inflammation. Mesenchymal stem cells (MSCs) have been shown to alleviate type 2 inflammation by modulating T lymphocyte subsets and decreasing T(H)2 cytokine levels. However, the effects of MSCs on ILC2s...
Autores principales: | Fan, Xingliang, Xu, Zhi‐Bin, Li, Cheng‐Lin, Zhang, Hong‐Yu, Peng, Ya‐Qi, He, Bi‐Xin, Liu, Xiao‐Qing, Chen, De‐Hua, Chen, Dong, Akdis, Cezmi A., Fu, Qing‐Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360040/ https://www.ncbi.nlm.nih.gov/pubmed/33662168 http://dx.doi.org/10.1002/stem.3369 |
Ejemplares similares
-
The ICOS–ICOSL pathway tunes thymic selection
por: Dong, Mengqi, et al.
Publicado: (2022) -
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo
por: Stoppa, Ian, et al.
Publicado: (2022) -
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction
por: Nayar, Saba, et al.
Publicado: (2022) -
MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells
por: Zheng, Zhong, et al.
Publicado: (2017) -
MicroRNA-146a regulates ICOS–ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres
por: Pratama, Alvin, et al.
Publicado: (2015)